Content about National Multiple Sclerosis Society

December 17, 2013

Three organizations will receive part of $1.3 million in funding that German drug maker Merck KGaA and the National Multiple Sclerosis Society are distributing for MS research.

NEW YORK — Three organizations will receive part of $1.3 million in funding that German drug maker Merck KGaA and the National Multiple Sclerosis Society are distributing for MS research.

EMD Serono, the name the Merck KGaA uses in the United States to avoid confusion with U.S.-based Merck & Co., and the National MS Society said the money will help encourage early-stage drug discovery for the autoimmune disease.

September 27, 2013

The National Multiple Sclerosis Society is putting $7 million toward research into ways to speed repair of the nervous system in patients with MS, the organization said Friday.

NEW YORK — The National Multiple Sclerosis Society is putting $7 million toward research into ways to speed repair of the nervous system in patients with MS, the organization said Friday.

January 10, 2011

Hygenic/Performance Health, makers of Perform and Biofreeze pain relievers, donated Perform pain reliever product samples and coupons in support of the National Multiple Sclerosis Society 2011 Run to Stop MS, MS Walks and MS Bike events.

AKRON, Ohio — Hygenic/Performance Health, makers of Perform and Biofreeze pain relievers, donated Perform pain reliever product samples and coupons in support of the National Multiple Sclerosis Society 2011 Run to Stop MS, MS Walks and MS Bike events.

September 21, 2010

The Food and Drug Administration has approved a drug for reducing relapses in patients with...

SILVER SPRING, Md. The Food and Drug Administration has approved a drug for reducing relapses in patients with multiple sclerosis.

 

The FDA announced Wednesday the approval of Swiss drug maker Novartis’ Gilenia (fingolimod) capsules, saying it was the first oral drug that can slow the progression of disability in patients with MS and offered an alternative to injected drugs.

 

 

Around 400,000 people in the United States and 2.1 million worldwide have MS, according to the National Multiple Sclerosis Society.